Abstract
Animal and human studies have shown angiotensin converting enzyme (ACE) inhibitors to be protective agents against myocardial injury, especially ischemia/reperfusion injury. In this review of the application of ACE inhibitors in heart surgery, I examine the problems involved and discuss their solutions.
Keywords: ace inhibitor, heart, surgery, ischemia, reperfusion, review
Letters in Drug Design & Discovery
Title: The Application of Angiotensin Converting Enzyme Inhibitors in Heart Surgery
Volume: 2 Issue: 2
Author(s): Yasuyuki Shimada
Affiliation:
Keywords: ace inhibitor, heart, surgery, ischemia, reperfusion, review
Abstract: Animal and human studies have shown angiotensin converting enzyme (ACE) inhibitors to be protective agents against myocardial injury, especially ischemia/reperfusion injury. In this review of the application of ACE inhibitors in heart surgery, I examine the problems involved and discuss their solutions.
Export Options
About this article
Cite this article as:
Shimada Yasuyuki, The Application of Angiotensin Converting Enzyme Inhibitors in Heart Surgery, Letters in Drug Design & Discovery 2005; 2 (2) . https://dx.doi.org/10.2174/1570180053175124
DOI https://dx.doi.org/10.2174/1570180053175124 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Anti-Cancer Agents in Medicinal Chemistry Coronary Microcirculation in Ischemic Heart Disease
Current Pharmaceutical Design Adenosine and Inflammation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Novel Strategies in the Treatment of Pulmonary Arterial Hypertension
Current Drug Targets Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Mechanical Intervention for Acute Myocardial Infarction
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Suicidal Inactivation of Methemoglobin by Generation of Thiyl Radical: Insight into NAC Mediated Protection in RBC
Current Molecular Medicine The Economic Costs for the Control of Cardiovascular Risk: An Overview
Current Pharmaceutical Design Do Adenosine Receptors Offer New Therapeutic Options for Diabetic Nephropathy?
Current Vascular Pharmacology Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume II)
CNS & Neurological Disorders - Drug Targets Monitoring Inflammation, Humoral and Cell-mediated Immunity in Pancreas and Islet Transplants
Current Diabetes Reviews In Silico Identification of Novel Orthosteric Inhibitors of Sphingosine Kinase 1 (SK1)
Current Protein & Peptide Science Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Current Pharmaceutical Design Aquaporin and Vascular Diseases
Current Neuropharmacology Therapeutic Potential of Endothelial Progenitor Cells for Cardiovascular Diseases
Current Vascular Pharmacology Melatonin in Pregnancy: Effects on Brain Development and CNS Programming Disorders
Current Pharmaceutical Design Protective Effects of Curcumin against Iron-induced Toxicity
Current Pharmaceutical Biotechnology Treatment of Pancreatic Cancer with Pharmacological Ascorbate
Current Pharmaceutical Biotechnology Stem Cell and Tissue Engineering Therapies for Ocular Regeneration
Current Stem Cell Research & Therapy Strategies for Enhancing Progenitor Cell Mobilization and Function in Diabetes
Current Vascular Pharmacology Mitochondrial Dynamics: An Emerging Paradigm in Ischemia-Reperfusion Injury
Current Pharmaceutical Design